MedTrace Logo

Validation of a Hypoparathyroidism Self-questionnaire

NCT05642741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of this study is to evaluate, for patients with post-thyroidectomy hypoparathyroidism (HoPT), the severity of their HoPT and to validate clinical scores from a self-administered questionnaire related to this disease (questionnaire which evaluates the severity of clinical symptoms related to HoPT and their impact on quality of life) in order to assess the severity of HoPT and to optimize support.

Conditions

  • Thyroidectomy
  • Hypoparathyroidism Postprocedural

Interventions

OTHER

Response to medical and research questionnaires

Patients will receive by mail or email the study information note, the medical questionnaire, the SF36 and the research questionnaire to be completed (then again 3 weeks later). The patients will return the questionnaires by mail or by post.

Sponsors & Collaborators

  • Fondation SantéDige

    collaborator UNKNOWN

  • Association Francophone de Chirurgie Endocrinienne (AFCE)

    collaborator UNKNOWN

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Eric MIRALLIE · Nantes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2023-12-10
Completion
2023-12-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05642741 on ClinicalTrials.gov